Correlation Between Monopar Therapeutics and CEMATRIX

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and CEMATRIX at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and CEMATRIX into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and CEMATRIX, you can compare the effects of market volatilities on Monopar Therapeutics and CEMATRIX and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of CEMATRIX. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and CEMATRIX.

Diversification Opportunities for Monopar Therapeutics and CEMATRIX

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Monopar and CEMATRIX is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and CEMATRIX in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CEMATRIX and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with CEMATRIX. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CEMATRIX has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and CEMATRIX go up and down completely randomly.

Pair Corralation between Monopar Therapeutics and CEMATRIX

Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 6.07 times more return on investment than CEMATRIX. However, Monopar Therapeutics is 6.07 times more volatile than CEMATRIX. It trades about 0.05 of its potential returns per unit of risk. CEMATRIX is currently generating about 0.03 per unit of risk. If you would invest  1,840  in Monopar Therapeutics on November 5, 2024 and sell it today you would earn a total of  2,554  from holding Monopar Therapeutics or generate 138.8% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Monopar Therapeutics  vs.  CEMATRIX

 Performance 
       Timeline  
Monopar Therapeutics 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Monopar Therapeutics are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Monopar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
CEMATRIX 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CEMATRIX has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Monopar Therapeutics and CEMATRIX Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monopar Therapeutics and CEMATRIX

The main advantage of trading using opposite Monopar Therapeutics and CEMATRIX positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, CEMATRIX can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CEMATRIX will offset losses from the drop in CEMATRIX's long position.
The idea behind Monopar Therapeutics and CEMATRIX pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated